Drugs in the Pipeline Oral Glucokinase Activator Gets Breakthrough Tx Status for Type 1 Diabetes By Brian Park, PharmD Publish Date April 13, 2021
Drugs in the Pipeline Trial Evaluating Dapagliflozin in Hospitalized COVID-19 Patients Misses Endpoints By Brian Park, PharmD Publish Date April 12, 2021
News Ozempic Injection 1mg Now Available as a Single Monthly Pen By Brian Park, PharmD Publish Date April 5, 2021
News Aflibercept Cuts Vision-Threatening Complications of Diabetic Retinopathy Publish Date March 31, 2021
News More Tepezza Will Be Available Starting in April By Diana Ernst, RPh Publish Date March 30, 2021
News SGLT2 Inhibitor Use Linked to Reduced Risk of Atrial Arrhythmias in T2DM Patients By Cassandra Pardini, PharmD Publish Date March 25, 2021
News Zegalogue Approved for Severe Hypoglycemia in Patients With Diabetes By Diana Ernst, RPh Publish Date March 23, 2021
News Albuminuria Reduction Greater With SGLT2 Inhibitor, ERA Combo By Natasha Persaud Publish Date March 18, 2021
Drugs in the Pipeline Pancreatic Islet Replacement Therapy Fast Tracked for Type 1 Diabetes By Brian Park, PharmD Publish Date March 10, 2021
Drugs in the Pipeline Tirzepatide Superior to Semaglutide in Head-to-Head Type 2 Diabetes Study By Diana Ernst, RPh Publish Date March 4, 2021
News Thyquidity Oral Solution Now Available for Hypothyroidism By Brian Park, PharmD Publish Date February 24, 2021
News Significant HbA1c, Body Weight Reductions With Tirzepatide in T2D Studies By Brian Park, PharmD Publish Date February 17, 2021
News Canagliflozin May Reduce Anemia Risk in Diabetic CKD By Natasha Persaud Publish Date February 3, 2021